 Importance RAA system treatment patients ACE inhibition myocardial infarction activation renin angiotensin system uncomplicated myocardial infarction Angiotensin II myocardial oxygen consumption coronary flow myocardium Angiotensin enzyme inhibitors beneficial haemodynamic neuroendocrine changes patients acute ventricular failure role patients cardiogenic shock evidence development late cardiac failure extent post infarction ventricular dilation Further research necessary role treatment acute myocardial infarction